Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-05-29

FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a labeling supplement for a combined oral contraceptive containing norethindrone acetate, ethinyl estradiol, and ferrous fumarate (Glenmark).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (Norethindrone acetate and ethinyl estradiol and ferrous fumarate)

Snippet

SUPPL AP for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)